

Shrinking AI for use in farms and clinics, ethical dilemmas for USAID researchers, and how to evolve evolvability
26 snips Feb 20, 2025
Martin Enserink, Deputy News Editor at Science, discusses the ethical dilemmas faced by researchers due to funding cuts in USAID-backed studies, emphasizing the impact on trial participants. Sandeep Ravindran shares insights on TinyML technology powering low-cost solutions in agriculture and healthcare, aiding farmers and clinics in the Global South. Michael Barnett reveals his research on evolving evolvability in microorganisms, exploring how these organisms adapt to environmental changes, showcasing the innovative intersection of evolution and technology.
AI Snips
Chapters
Transcript
Episode notes
USAID's Role in Global Health
- USAID supports global health initiatives, including research and HIV treatment programs.
- The recent funding freeze has disrupted these programs, impacting clinical trials and data collection.
Halted HIV Prevention Trial
- In South Africa, a clinical trial of an HIV prevention ring was halted due to the funding freeze.
- Participants had to have the rings removed, causing distress and raising concerns.
Risks of Halting HIV Prevention Trials
- Halting an HIV prevention drug trial in Africa could have severe consequences.
- Participants face increased infection risk and potential drug resistance.